Role of imaging in clinical trials of antiangiogenesis therapy in oncology
- PMID: 11048877
- DOI: 10.1016/s1076-6332(00)80628-5
Role of imaging in clinical trials of antiangiogenesis therapy in oncology
Similar articles
-
NCI to sponsor phase III trials of liquid shark cartilage angiogenesis inhibitor.Oncology (Williston Park). 1999 Jan;13(1):82. Oncology (Williston Park). 1999. PMID: 10223792 No abstract available.
-
Antiangiogenesis as a novel therapeutic concept in pediatric oncology.J Mol Med (Berl). 1995 Oct;73(10):497-508. doi: 10.1007/BF00198901. J Mol Med (Berl). 1995. PMID: 8581511 Review. No abstract available.
-
National Cancer Institute initiative for development of novel imaging technologies.Acad Radiol. 2000 Jun;7(6):481-3. doi: 10.1016/s1076-6332(00)80427-4. Acad Radiol. 2000. PMID: 10845407 No abstract available.
-
2015 ASCO Annual Meeting.Lancet Oncol. 2015 Jul;16(7):755-6. doi: 10.1016/S1470-2045(15)00025-X. Epub 2015 Jun 7. Lancet Oncol. 2015. PMID: 26062778 No abstract available.
-
The role of imaging in the clinical development of antiangiogenic agents.Hematol Oncol Clin North Am. 2004 Oct;18(5):1183-206, x. doi: 10.1016/j.hoc.2004.06.011. Hematol Oncol Clin North Am. 2004. PMID: 15474341 Review.
Cited by
-
Evaluation of new morphometric parameters of neoangiogenesis in human colorectal cancer using confocal laser endomicroscopy (CLE) and targeted panendothelial markers.PLoS One. 2014 Mar 10;9(3):e91084. doi: 10.1371/journal.pone.0091084. eCollection 2014. PLoS One. 2014. PMID: 24614504 Free PMC article.
-
Clinical biomarkers of angiogenesis inhibition.Cancer Metastasis Rev. 2008 Sep;27(3):415-34. doi: 10.1007/s10555-008-9143-x. Cancer Metastasis Rev. 2008. PMID: 18414993 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical